Voss Value Master Fund, LP - Insider Non-Derivative Transactions at Rein Therapeutics, Inc. (RNTX) - (SEC)
Updated on March 12, 2026.
According to recent SEC insider information filed on Nov 14, 2025, Voss Value Master Fund, LP's relationship to Rein Therapeutics, Inc. (RNTX) is TenPercentOwner, and currently has 926,441 shares of Common Stock, $0.001 par value.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RNTX insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Voss Value Master Fund, LP - Insider Non-Derivative Transactions at RNTX
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 15, 2025 | P -- (Common Stock, $0.001 par value) | 104183 | 1.22 | 926441 |